IDHIFA vs TIBSOVO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. IDHIFA and TIBSOVO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IDHIFA	TIBSOVO
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ENASIDENIB MESYLATE	IVOSIDENIB
Manufacturer	Bristol Myers Squibb	Servier
Dosage forms	Tablet	Tablet
Drug class	Isocitrate Dehydrogenase 2 Inhibitor	—
Boxed warning	Boxed warning	Boxed warning
Treats	Acute Myeloid Leukemia	Acute Myeloid Leukemia

idhifa tibsovo

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

ENASIDENIB MESYLATE

IVOSIDENIB

Manufacturer

Bristol Myers Squibb

Servier

Dosage forms

Tablet

Drug class

Isocitrate Dehydrogenase 2 Inhibitor

—

Boxed warning

Treats

Acute Myeloid Leukemia

Frequently asked questions

What is the difference between Idhifa and Tibsovo?

Idhifa contains Enasidenib Mesylate, while Tibsovo contains Ivosidenib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.